MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Prostate Cancer Diagnosis and Treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

4,757 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
4,757 works in the cohort · of 4,299,418page 69 of 96

Labels cover 22 of 4,757 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 4,757 of 4,757 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Prostate Cancer Screening
Anthony B. Miller
2012· other· en· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Costs of treatments for local/regional prostate cancer
Claire Snyder, Kevin D. Frick, Amanda L. Blackford, Robert J. Herbert, Bridget A. Neville, Michael A. Carducci +1 more
2009· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
afffundaboutunlabeled
5-α Reductase Inhibitors and Prostate Cancer Mortality
Robert J. Hamilton, Julián Chavarriaga, Najia Khurram, Cindy Lau, Jin Luo, Ning Liu +6 more
2024· article· en· JAMA Network Open· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
Radiotherapy for T3 prostate cancer
Andrew Bayley, Mary Gospodarowicz
2003· review· en· Current Urology Reports· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
The drama of prostate cancer diagnostics
Ola Bratt, Jonas Hugosson, Laurence Klotz, Vincent J. Gnanapragasam
2017· letter· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
2786
Ivan Yeung, S. Chen, Yonggwi Cho, Daniel Taussky, Akbar Beiki‐Ardakani, J. Crook
2006· article· en· International Journal of Radiation Oncology*Biology*Physics· Medicine
machine prediction:candidate · insufficient_payloadconsensus · none
2
citations

How this was built: Screen · Findings · About